Food Recall Warning - Certain Tri-Star Seafood Supply Ltd. brand Live Spot Prawns recalled due to norovirus
OTTAWA, ON, May 31, 2022 /CNW/ -
Summary
Brand(s): Tri-Star Seafood Supply Ltd.
Product: Certain Live Spot Prawns
Companies: Tri-Star Seafood Supply Ltd.
Issue: Food ? Microbial contamination ? Norovirus
Category: Fish and seafood (Fresh)
What to do: Do not consume, use, sell, serve, or distribute the recalled product
Audience: General public; Hotels, restaurants and institutions
Recall class: Class 2
Affected products
Brand
Product
Size
UPC
Codes
Tri-Star Seafood Supply Ltd.
Live Spot Prawn
Variable
None
AJ200-021
CA001-1532
CA001-1540
Issue Tri-Star Seafood Supply Ltd. is recalling certain Tri-Star Seafood Supply Ltd. brand Live Spot Prawns from the marketplace due to possible norovirus contamination.
The recalled product has been sold in British Columbia, Alberta, Manitoba, and Ontario, and may have been distributed in other provinces and territories.
What you should do
If you think you became sick from consuming a recalled product, call your doctor
Check to see if you have the recalled product in your home or establishment
Do not consume the recalled product
Do not serve, use, sell, or distribute the recalled product
Recalled products should be thrown out or returned to the location where they were purchased
Consumers who are unsure if they have purchased the affected product are advised to contact their retailer
People with norovirus illness usually develop symptoms of gastroenteritis within 24 to 48 hours, but symptoms can start as early as 12 hours after exposure. The illness often begins suddenly. Even after having the illness, you can still become re-infected by norovirus. The main symptoms of norovirus illness are diarrhea, vomiting (children usually experience more vomiting than adults), nausea and stomach cramps. Other symptoms may include low-grade fever, headache, chills, muscle aches and fatigue (a general sense of tiredness). Most people feel better within one or two days, with symptoms resolving on their own, and experience no long-term health effects. As with any illness causing diarrhea or vomiting, people who are ill should drink plenty of liquids to replace lost body fluids and prevent dehydration. In severe cases, patients may need to be hospitalized and given fluids intravenously.
This recall was triggered by findings by the Canadian Food Inspection Agency during its investigation into a foodborne illness outbreak.
There have been reported illnesses associated with the consumption of this product.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.
The CFIA is verifying that industry is removing the recalled product from the marketplace.
On or around February 6, 2024, Hypertension-Nephrology Associates, P.C. ("the Practice") became aware it was the target of an extortion attack when an extortion note was found on its computer system. Upon discovery of the extortion note, the Practice...
Dr. Scott McMahon of Whole World Health Care is happy to announce the 2024 annual Surviving Mold-CIRSx Conference, set to be held May 16-19, 2024 at the Hyatt Regency, located at 2615 Preston Road in Frisco, Texas, a city near Dallas. CIRSx was...
PDS Health®, a leading U.S. provider of integrated healthcare support services, proudly announces its recognition as one of The Civic 50 honorees of 2024 by Points of Light, the world's largest nonprofit dedicated to accelerating people-powered...
Note: All times local
Quebec City, Quebec
9:30 a.m.
The Prime Minister will take part in an historic announcement about the Québec Bridge. The Minister of Public Services and Procurement, Jean-Yves Duclos, and the Minister of Transport and Quebec...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
Andlauer Healthcare Group Inc. ("AHG" or the "Company") today announced that the Board has approved a substantial issuer bid (the "Offer") under which the Company will offer to purchase for cancellation up to 2,000,000 subordinate voting shares of...